408
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of Single vs Combination Drug Therapy in Extensively Drug Resistant Salmonella typhi: An Observational Study from Pakistan

, , &
Pages 6093-6100 | Received 24 Apr 2022, Accepted 01 Aug 2022, Published online: 21 Oct 2022

References

  • World Health Organisation. Typhoid Fact Sheet. Available from: https://www.who.int/news-room/fact-sheets/detail/typhoid. Accessed September 12, 2022.
  • Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med. 2002;347(22):1770–1782. doi:10.1056/NEJMra020201
  • Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997;24(Suppl 1):S106–9. doi:10.1093/clinids/24.Supplement_1.S106
  • Wong MH, Yan M, Chan EW, Biao K, Chen S. Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. Antimicrob Agents Chemother. 2014;58(7):3752–3756. doi:10.1128/AAC.02770-13
  • Akram J, Khan AS, Khan HA, et al. Extensively drug-resistant (XDR) typhoid: evolution, prevention, and its management. Biomed Res Int. 2020;2(2020):6432580.
  • Klemm EJ, Shakoor S, Page AJ, et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third generation cephalosporins. MBio. 2018;9(1):e00105–18. doi:10.1128/mBio.00105-18
  • National Institute of health. Government of Pakistan. seasonal awareness and alert letter. Available from: https://www.nih.org.pk/wp-content/uploads/2021/10/52nd-Issue-SAAL-print-VERSION-11-OCTOBER-2021.pdf. Accessed September 12, 2022.
  • Wang Y, Dan L, Yingying J, et al. Extensively drug-resistant (XDR) Salmonella Typhi outbreak by waterborne infection — Beijing Municipality, China, January–February 2022. China CDC Weekly. 2022;4(12):254–258. doi:10.46234/ccdcw2022.062
  • Medical Microbiology & Infectious Diseases Society of Pakistan. Typhoid Management Guidelines; 2019. Available from: https://www.mmidsp.com/typhoid-management-guidelines-2019/. Accessed September 12, 2022.
  • Qureshi S, Naveed AB, Yousafzai MT, et al. Response of extensively drug resistant Salmonella Typhi to treatment with meropenem and azithromycin. Pakistan PLoS Negl Trop Dis. 2020;14(10):e0008682. doi:10.1371/journal.pntd.0008682
  • Yousafzai MT, Irfan S, Thobani RS, et al. Burden of culture confirmed enteric fever cases in Karachi, Pakistan: Surveillance for Enteric fever in Asia project (SEAP), 2016–2019. Clin Infect Dis. 2020;71(Suppl 3):S214–S221. doi:10.1093/cid/ciaa1308
  • Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India. 2009;65(4):328–331. doi:10.1016/S0377-1237(09)80093-2
  • Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2008;(4). doi:10.1002/14651858.CD006083.pub2
  • Butler T. Treatment of typhoid fever in the 21st century promises and shortcomings. Clin Microbiol Infect. 2011;17(7):959–963. doi:10.1111/j.1469-0691.2011.03552.x
  • Shahid S, Mahesar M, Ghouri N, Noreen S. A review of clinical profile, complications and antibiotic susceptibility pattern of extensively drug-resistant (XDR) Salmonella Typhi isolates in children in Karachi. BMC Infect Dis. 2021;21(1):900. doi:10.1186/s12879-021-06599-2
  • Munir T, Lodhi M, Ansari JK, Andleeb S, Ahmed M. Extended spectrum beta lactamase producing cephalosporin resistant Salmonella Typhi, reported from Rawalpindi, Pakistan. J Pak Med Assoc. 2016;66(8):1035–1036.
  • Sajib MS, Tanmoy AM, Hooda Y, et al. Tracking the emergence of azithromycin resistance in multiple genotypes of typhoidal Salmonella. Mbio. 2021;12(1):e03481–20. doi:10.1128/mBio.03481-20
  • World health organization. Target product profile for therapy of uncomplicated enteric fever. Available from: file:///C:/Users/User/Desktop/9789240003835-eng.pdf. Accessed September 12, 2022.
  • Vighio A, Syed MA, Hussain I, et al. Risk factors of extensively drug resistant typhoid fever among children in Karachi: case-control study. JMIR Public Health Surveill. 2021;7(5):e27276. PMID: 33973861; PMCID: PMC8150408. doi:10.2196/27276
  • Qamar FN, Yousafzai MT, Khaliq A, et al. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan. Vaccine. 2020;38(19):3518–3523. doi:10.1016/j.vaccine.2020.03.028